Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Breast Cancer treatment details. Chemotherapy. Indiana University, Indianapolis, IN, United States



Survival: 14.5 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs: Xeloda
Country: United States
   
City/State/Province: Indianapolis, IN
   
Hospital: Indiana University
   
Journal: Link
   
Date: 2/2005

Description:
Patients: This Phase III study involved 462 women with metastatic breast cancer. The patients were randomly divided into two groups. In Group A, there were 230 patients mean age 52).

Treatment: The treatment for Group A consisted of one chemotherapeutic agent: capecitabine.

Toxicity: In Group A, Grade 3-4 toxicities included diarrhea, stomatitis, hand-foot syndrome, asthenia, and leukopenia.

Results: The median overall survival for Group A was 14.5 months.

Support: Genentech financially supported this study, and several authors were employed by and have financial interests in Genentech. Genentech manufactures and markets bevacizumab (a drug that was administered to patients in Group B).

Correspondence: Kathy D. Miller, M.D.

E-mail to a Friend Email Physician More Information